Unlike traditional cell therapies that require harvesting and re-engineering a patient's cells outside the body, Sail's platform is designed to reprogram immune cells directly inside the body, an approach the companies say could make CAR T manufacturing simpler and more scalable while delivering durable, potentially curative results
Empower does not accept insurance for compounded semaglutide
a , Schematic of genetically encoded dopamine sensor, AAV-dLight1.3b, injection and fibre-optic implant in the NAc of Glp1r S33W mice
This lets you capture the benefits of GLP-1 agonism at lower cost
As we develop metabolic dysfunction, insulin resistance, or hormonal imbalances, these natural signaling pathways become disrupted
Safety Considerations Usually well-tolerated in research studies